2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl]-6-quinazolinyl]-, 4-methyl benzenesulfonate (1:2)

CAS : 451493-31-5

Ref. 3D-BTA49331

Informations sur le produit

• Nom: 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl]-6-quinazolinyl]-, 4-methyl benzenesulfonate (1:2)
• Synonymes: AV 412, 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butynyl]-6-quinazolinyl]-, bis(4-methylbenzenesulfonate), MP 412, 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl]-6-quinazolinyl]-, 4-methylbenzenesulfonate (1:2), AV 412 tosylate

Description

N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl]-6-quinazolinyl]2,2′:6′,2″:6″,6′″-(tertiary butoxycarbonylamino)biphenyl (DG3178) is a novel small molecule that has shown the potential to inhibit tumor growth and progression in vivo. It is an inhibitor of receptor tyrosine kinases (RTKs), which are involved in the signaling of epidermal growth factor (EGF) and other growth factors. DG3178 inhibited tumor cell proliferation through inhibition of EGFR and HER2/neu receptor tyrosine kinases. In addition, it has been shown to induce regression in human epidermal growth factor receptor 2 (HER2)-positive breast cancer

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 851.42 g/mol
• Formule: C₂₇H₂₈ClFN₆O·2C₇H₈O₃S
• Degré de pureté: Min. 95%